Kirpal S DhaliwalSanta Ana, CA
Kirpal Dhaliwal Phones & Addresses
Santa Ana, CA
Mentions for Kirpal S Dhaliwal
Publications & IP owners
Us Patents
Method And Composition For Treatment Of Premenstrual Syndrome In Women
US Patent:
6589569, Jul 8, 2003
Filed:
Oct 30, 2000
Appl. No.:
09/698662
Inventors:
Kirpal S Dhaliwal - Bell Gardens CA, 90201
International Classification:
A61K 3578
US Classification:
424725, 424773, 424774, 424775, 424776, 424777, 424779
Abstract:
A medicinal composition has been created that is useful in the treatment of PMS in human females who experience adverse PMS symptoms. The composition is comprised of an extract of asparagus racemosus. The composition preferably includes about eighty-five parts and about five parts each of , , and. The active component of the is saponin glucoside (A4). Preferably, the composition is administered in capsular form with each capsule containing about one-half gram of the composition. Two of these capsules are taken three times a day.
Method And Composition For Treatment Of Diabetes
US Patent:
5886029, Mar 23, 1999
Filed:
Sep 5, 1997
Appl. No.:
8/924512
Inventors:
Kirpal S. Dhaliwal - Bell Gardens CA
International Classification:
A61K 3135
A61K 3578
A61K 3578
US Classification:
514456
Abstract:
A medicinal composition is provided for treatment of diabetes in a human subject. The medicinal composition of the invention induces a significant reduction in serum glucose due to the regeneration of pancreatic islet cells. A medicinal composition according to the invention necessarily includes a pharmacologically significant quantity of (-)epicatechin augmented with a comparable amount of gymnemic acid. For best results smaller quantities of cinnamomum tamala, syzygium cumini, trigonella foenum graceum, azardichta indica, ficus racemosa, and tinospora cordifolia are also included in the composition. One to two grams of the medicinal composition of the invention are administered to a diabetic human subject three times a day before meals. The unique combination of components in the medicinal composition leads to a regeneration of the pancreas cells which then start producing insulin on their own. Since the composition restores normal pancreatic function, treatment can be discontinued after between about four and twelve months.
NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.